Nasal Antiseptics Market Trends

  • Report ID: 5650
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Nasal Antiseptics Market Trends

Growth Drivers

  • Increased Research & Development Activities in the Antibiotics Industry - Rethinking adult acute sinusitis treatment is becoming increasingly relevant. Antibiotic usage is a major concern in many nations due to drug-resistant microorganisms. This has resulted in increased morbidity, mortality, and costs for both individuals and healthcare systems. Businesses in the sinus or nasal decontamination treatment industry are investing in R&D to provide patients with more effective treatment options, which is expected to drive market growth. Antibiotics are predicted to be the second most popular therapeutic category, with significant growth. Recent studies on the effectiveness of antibiotics for acute sinusitis have excluded patients with severe illnesses or co-existing conditions like pulmonary disorders and diabetes.
  • Increasing Elderly Population Worldwide - The nasal antiseptics market is expected to grow due to an increase in elderly patients suffering from chronic rhinosinusitis with nasal polyps (CRSwNP), the adoption of minimally invasive surgeries by otorhinolaryngology surgeons, and the availability of treatment options for nasal polyps through expanding research. Therefore, the growing elderly population globally is propelling the growth of the market. For instance, the global population of over 65 is expected to more than quadruple, from 761 million in 2021 to 1.6 billion in 2050. The number of people over 80 years old is rapidly increasing.
  • Growing Awareness Regarding the Benefits of the Product - It reduces the growth of bacteria that might cause skin infections in patients. To make the nose safe before surgery, a broad-spectrum nasal antiseptics kit is utilized to prepare the skin. It is designed for professional and hospital use and can be stored at room temperature. Its ease of storing leads to widespread adoption in the business. It is commonly used in healthcare to prevent infection among patients. It also reduces the bacterial burden, which adds to a lower risk of illness in personnel and patients.

Challenges

  • Severe Side Effects of the Product – Nasal antiseptics may cause minor to severe adverse effects. Common adverse effects include rashes, hives, itching, and blisters. Some severe adverse effects include chest or throat tightness, difficulty breathing, and mouth swelling. As a result, this issue may limit the growth of the market.
  • Stringent Regulations and Laws may Hamper the Market Growth
  • Increased Competition from Alternative Products in the Market may Hinder Market Growth

Nasal Antiseptics Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

5.3%

Base Year Market Size (2024)

USD 353.92 million

Forecast Year Market Size (2037)

USD 692.59 million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5650
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of nasal antiseptics is evaluated at USD 368.93 million.

The nasal antiseptics market size was over USD 353.92 million in 2024 and is poised to exceed USD 692.59 million by 2037, witnessing over 5.3% CAGR during the forecast period i.e., between 2025-2037. Increased research & development activities in the antibiotics industry, increasing elderly population worldwide, and growing awareness regarding the benefits of the product will boost the market growth.

North America industry is estimated to hold largest revenue share of 36% by 2037, due to rising sinus infection prevalence in the region.

The major players in the market are BlueWillow Biologics®, Silicon Valley Innovations, Inc. (SVI), Siemens Healthineers, Hoffmann-La Roche Ltd., Abbott Laboratories, Horiba Ltd., Danaher Corp., OmegaQuant LLC, Sysmex Corporation, EKF Diagnostics Holdings Plc, Maruishi Pharmaceutical. Co., Ltd., 3M, NIHON CHOUZAI Co., Ltd., Shionogi & Co., Ltd., Aculys Pharma, Inc. and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample